Publikationer pr. år
Publikationer pr. år
Personlig profil
Expertise
Lars Erik Kristensen is chief scientific officer (CSO) at the parker institute. He operates as part leader and part doer with the responsibility of ensuring that the scientific projects support the strategy elements of the Parker Institute.
"
Primære forskningsområder
Lars Erik Kristensens’ current research activities are focused around efficacy and tolerability of anti-TNF treatment and other 2nd generation biologicals in chronic arthritis both in controlled trial settings and observational cohort studies.
Aktuel forskning
Over the recent years, especially spondylarthritis have been studied also from an epidemiologic perspective. Exploring different outcome measures have gained increasing focus addressing interventions from a patient, societal, and clinical perspective.
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Lars Erik Kristensen er aktive. Disse emneetiketter kommer fra denne persons arbejder. Sammen danner de et unikt fingerprint.
- 1 Lignende profiler
Samarbejde og topforskningsområder i de sidste fem år
Seneste eksterne samarbejde på lande-/områdeniveau. Dyk ned i detaljerne ved at klikke på prikkerne eller
-
Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib
Kristensen, L. E., Strober, B., Poddubnyy, D., Leung, Y-Y., Jo, H., Kwok, K., Vranic, I., Fleishaker, D. L., Fallon, L., Yndestad, A. & Gladman, D. D., 2023, I: Therapeutic Advances in Musculoskeletal Disease. 15, s. 1759720X221149965Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants: A population-based, matched cohort study
Harboe, Z. B., Roed, C., Holler, J. G., Khan, F. I., Abdulrahman, A. N. A., Mulverstedt, S. L., Lindgaard-Jensen, B., Bertelsen, B. B., Søborg, C., Nielsen, T. L., Hansen, L. V., Madsen, B. L., Browatzki, A., Eiberg, M., Bernhard, P. H., Pedersen, E. M. J., Egelund, G. B., Dungu, A. M., Sejdic, A., Mathiesen, I. H. M., & 54 flere, apr. 2023, I: PLoS One. 18, 4, s. e0282806 e0282806.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
1 Citationer (Scopus) -
Cytokine Signatures in Psoriatic Arthritis Patients Indicate Different Phenotypic Traits Comparing Responders and Non-Responders of IL-17A and TNFα Inhibitors
Skougaard, M., Ditlev, S. B., Søndergaard, M. F. & Kristensen, L. E., 28 mar. 2023, I: International Journal of Molecular Sciences. 24, 7, 6343.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 study
Kristensen, L. E., Keiserman, M., Papp, K., McCasland, L., White, D., Lu, W., Soliman, A. M., Eldred, A., Barcomb, L. & Behrens, F., 1 jun. 2023, I: Rheumatology (Oxford, England). 62, 6, s. 2113-2121 9 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Exercise and education versus intra-articular saline for knee osteoarthritis: A 1-year follow-up of a randomized trial
Henriksen, M., Christensen, R., Kristensen, L. E., Bliddal, H., Bartholdy, C., Boesen, M., Ellegaard, K., Guldberg-Møller, J., Hunter, D. J., Altman, R. & Bandak, E., maj 2023, I: Osteoarthritis and Cartilage. 31, 5Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review